62880-0

PhenX - conditions relevant to immune response - screener - child protocol 160802

Active

Term Description

This screening protocol includes nine proxy-administered questions from the Centers for Disease Control and Prevention (CDC) Screening Questionnaire for Child and Teen Immunization. Parents or guardians are asked to respond to yes-or-no questions. The PhenX Infectious Diseases and Immunity Working Group recommend that this protocol only be used for exclusionary purposes based on contraindications.

Reference Information

Type	Source	Reference
Citation	Consensus measures for Phenotypes and Exposures	Department of Health and Human Services. Centers for Disease Control and Prevention (2009). Screening Questionnaire for Child and Teen Immunization. Questions 1-9.

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINC	Name	R/O/C	Cardinality	Example UCUM Units
62880-0	PhenX - conditions relevant to immune response - screener - child protocol 160802
Indent66383-1	Is the child sick today?
Indent66384-9	Does the child have allergies to medications, food, or any vaccine?
Indent66385-6	Has the child had a serious reaction to a vaccine in the past?
Indent66386-4	Has the child had a seizure or a brain problem?
Indent66387-2	Does the child have cancer, leukemia, AIDS, or any other immune system problem?
Indent66388-0	Has the child take cortisone, prednisone, other steroids, or anticancer drugs or had x-ray treatments in the past 3 months?
Indent66389-8	Has the child received a transfusion of blood or blood products or been given a medicine called immune (gamma) globulin in the past year?
Indent66390-6	Is the child/teen pregnant, or is there a chance she could become pregnant during the next month?
Indent66391-4	Has the child received vaccinations in the past 4 weeks?

LOINC Names Get Info

Fully-Specified Name: PhenX - conditions relevant to immune response - screener - child protocol 160802:-:Pt:^Patient:-:PhenX
Long Common Name: PhenX - conditions relevant to immune response - screener - child protocol 160802
Short Name: Immune response - child proto

Part Model Get Info

Component
PhenX - conditions relevant to immune response - screener - child protocol 160802
LP112437-1
- Analyte
  PhenX - conditions relevant to immune response - screener - child protocol 160802
  LP112437-1
  - Component Numerator
    PhenX - conditions relevant to immune response - screener - child protocol 160802
    LP112437-1
    - Component Numerator Core
      PhenX - conditions relevant to immune response - screener - child protocol 160802
      LP112437-1
    - Component Numerator Core Suffix
      NULL
  - Component Denominator
    NULL
    - Component Denominator Core
      NULL
    - Component Denominator Core Suffix
      NULL
- Challenge
  NULL
- Adjustment
  NULL
- Count
  NULL
Property
-
LP6769-6
Time
Pt
LP6960-1
- Time Core
  Pt
  LP6960-1
- Time Modifier
  NULL
System
^Patient
LP310005-6
- System Core
  NULL
- Super System
  Patient
  LP6985-8
Scale
-
LP7747-1
Method
PhenX
LP95333-8

Survey Question

: PX160802

Code System	Code	Code Text	Code Version
PhenX (Consensus measures for Phenotypes and Exposures)	160802	conditions_relevant_to_immune_response___screener_2

Basic Attributes

Class: PANEL.PHENX
Type: Clinical
First Released: Version 2.36
Last Updated: Version 2.81 (MIN)
Change Reason: Release 2.81: Status: Changing PhenX Concept from Status = Trial to Active; Previous Releases: Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.
Panel Type: Panel

Member of these Panels

LOINC	Long Common Name
62863-6	PhenX domain - Infectious diseases and immunity

Language Variants Get Info

Tag	Language	Translation
el-GR	Greek (Greece)	PhenX - παθήσεις που σχετίζονται με την ανοσολογική απόκριση- έλεγχος- πρωτόκολλο παίδων 160802:-:Pt:^Ασθενής:-:PhenX Synonyms: - PANEL.PHENX PHENX PhenX - παθήσεις που σχετίζονται με την ανοσολογική απόκριση- έλεγχος- πρωτόκολλο παίδων 160802 Pt Ασθενής
es-MX	Spanish (Mexico)	PhenX - condiciones relevantes para la respuesta inmune - evaluador - protocolo infantil 160802:-:Punto temporal:^ Paciente:-:PhenX
it-IT	Italian (Italy)	PhenX - condizioni rilevanti alla risposta immunitaria - screener - bambino, protocollo:-:Pt:^Paziente:-:PhenX Synonyms: Panel PhenX paziente PhenX Punto nel tempo (episodio)
ru-RU	Russian (Russian Federation)	PhenX - условия значимые для иммунного ответа - скринер - детский протокол:-:ТчкВрм:^Пациент:-:PhenX Synonyms: Точка во времени;Момент
zh-CN	Chinese (China)	PhenX - 与免疫应答相关的健康状况 - 筛查工具 - 儿童方案 160802:-:时间点:^患者:-:PhenX Synonyms: Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 Consensus measures for Phenotypes and eXposures;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 PhenX - 与免疫应答相关的状况 - 筛查工具 - 儿童方案 160802;PhenX - 与免疫应答相关的情况 - 筛查工具 - 儿童方案;PhenX - 与免疫应答相关的病情 - 筛查工具 - 儿童方案;PhenX - 与免疫应答相关的健康状况 - 筛查工具（筛查人员、筛查者） - 儿童方案;Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标医嘱套餐医嘱套餐类医嘱套餐组医嘱组医嘱组.PhenX;组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）.PhenX;Consensus measures for Phenotypes and eXposures;PhenX;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标;PhenX 医嘱组医嘱组合医嘱组合类医嘱组套医嘱组套类医嘱组类医疗服务对象;客户;病人;病患;病号;超系统 - 病人多重;多重型;多重标尺类型;多重精度类型套餐套餐医嘱套餐医嘱组套餐医嘱组类实验室医嘱套餐实验室医嘱套餐类实验室医嘱组实验室医嘱组合类实验室医嘱组套实验室医嘱组套类实验室套餐医嘱组实验室套餐医嘱组类实验室检验项目医嘱组合类实验室检验项目组合类时刻;随机;随意;瞬间检验医嘱组合类检验项目医嘱组合类检验项目组合类组组合组合医嘱组合类组套

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=62880-0
Questionnaire definition: https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/62880-0

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.